22h
GlobalData on MSNAsceneuron halts Alzheimer’s trial adding to tau-targeting setbacksAfter Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...
Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of Mersana Therapeutics in a ...
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
In January, the Pennsylvania Supreme Court issued an opinion that may require environmental practitioners to reconsider how ...
A sharply divided Supreme Court on Wednesday reinstated a lower-court order for the Trump administration to release frozen foreign aid, ...
We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look ...
ITAT Raipur held that dismissal of appeal by CIT (A) without disposing off on merits, merely on account of non-prosecution is ...
As Obesity Care Week (OCW) 2025 continues, supporters nationwide are rallying behind the Centers for Medicare & Medicaid Services (CMS) Proposed Rule, which could expand Medicare Part D coverage to ...
Quarles & Brady LLP's Insurance Recovery Team compiles a list of important decisions by Wisconsin state and federal courts ...
Broadcom and Nvidia are testing Intel’s advanced chip manufacturing process, signaling potential AI chip expansion. The tests ...
18hon MSN
The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results